K914862 is an FDA 510(k) clearance for the CEREBROVASCULAR DIAGNOSTIC SYSTEM. Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.
Submitted by Medasonics, Inc. (Fremont, US). The FDA issued a Cleared decision on December 3, 1992 after a review of 401 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Radiology submissions.
View all Medasonics, Inc. devices